Bertek apomorphine clears FDA
Executive Summary
Mylan subsidiary Bertek will launch Apokyn (apomorphine) as the first therapy approved to treat "off" episodes of Parkinson's disease by July after receiving FDA approval of the orphan drug product April 20...